For the department of public health, which may expend for the HIV Drug Assistance Program (HDAP) not more than $65,194,869 from revenues received from pharmaceutical manufacturers participating in the section 340B rebate program of the Public Health Service Act, administered by the federal health resources and services administration and the office of pharmacy affairs; provided, that these services shall include activities that would be eligible for coverage through the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, Public Law 101-381, with priority given to the human immunodeficiency virus and acquired immune deficiency syndrome drug assistance program; provided further, that any excess rebate revenue collected beyond the ceiling of this appropriation will be deposited in the General Fund; provided further, that services in an amount equivalent to the amount deposited in the General Fund be funded through the
4512-0103 appropriation; and provided further, that the department of public health may make expenditures from the start of each fiscal year from this account in anticipation of receipt of rebate revenues from pharmaceutical manufacturers
